Goldman Sachs Group »

Leap Therapeutics shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Leap Therapeutics (LPTX) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Leap Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Leap Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Leap Therapeutics by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2024-06-30 $34k 18k 1.96
2024-03-31 $49k 18k 2.66

More positions owned by Goldman Sachs Group

Spdr S&p 500 Etf Tr CMN (SPY)
Nvidia Corporation CMN (NVDA)
Microsoft Corp CMN (MSFT)
Apple CMN (AAPL)
Amazon CMN (AMZN)
Alphabet CMN (GOOGL)
Tesla CMN (TSLA)
Meta Platforms CMN (META)
Ishares Tr CMN (IVV)
Invesco Qqq Tr CMN (QQQ)
Ishares Tr CMN (IWM)
Vanguard Index Fds CMN (VOO)
Alphabet CMN (GOOG)
Visa CMN (V)
Ishares Tr CMN (EEM)

View all positions for Goldman Sachs Group

Top funds holding Leap Therapeutics

Balyasny Asset Management
Samsara BioCapital
683 Capital Management
Rock Springs Capital Management
Baker Bros. Advisors
Simplify Asset Management
Vanguard Group
Laurion Capital Management
Citadel Advisors
Geode Capital Management
Key Client Fiduciary Advisors
BlackRock
Acadian Asset Management
BlackRock
Dimensional Fund Advisors

View all funds holding Leap Therapeutics